VEGFR2/CD309 antibody
Quick Overview for VEGFR2/CD309 antibody (ABIN2385087)
Target
See all VEGFR2/CD309 (VEGFR2) AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Cross-Reactivity
- Human, Mouse (Murine)
-
Cross-Reactivity (Details)
- Calculated cross reactivity: Hu Mo
-
Characteristics
- VEGF Receptor 2 (CD309 antigen, Fetal liver kinase 1, FLK1, KDR, Kinase insert domain receptor, KRD1, Ly73, Protein tyrosine kinase receptor FLK1, Vascular endothelial growth factor receptor 2, VEGFR, VEGFR2)
-
Purification
- Purified by Protein A and peptide affinity chromatography.
-
Immunogen
- Synthetic phospho-peptide (KLH coupled) corresponding to residues surrounding Tyr951 of human VEGF receptor 2.
-
Isotype
- IgG
-
-
-
-
Application Notes
- Optimal working conditions should be determined by the investigator.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
- Supplied as a liquid in 10 mM HEPES, pH 7.5, 150 mM sodium chloride, 0.1 mg/mL BSA, 50 % glycerol. No preservative added.
-
Preservative
- Without preservative
-
Storage
- 4 °C,-20 °C
-
Storage Comment
- 4°C (-20°C Glycerol)
-
-
- VEGFR2/CD309 (VEGFR2) (VEGF Receptor 2 (VEGFR2))
-
Alternative Name
- VEGF Receptor 2
-
Pathways
- RTK Signaling, Glycosaminoglycan Metabolic Process, Signaling Events mediated by VEGFR1 and VEGFR2, Growth Factor Binding, Regulation of long-term Neuronal Synaptic Plasticity, VEGF Signaling
Target
-